In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Euglucon Drug Master File in Korea (Euglucon KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Euglucon. The MFDS reviews the Euglucon KDMF as part of the drug registration process and uses the information provided in the Euglucon KDMF to evaluate the safety and efficacy of the drug.
After submitting a Euglucon KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Euglucon API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Euglucon suppliers with KDMF on PharmaCompass.